PECAM1 and Alzheimer disease: Elevated peripheral mCRP during chronic inflammation leads to decreased CD31 expression and increased phosphorylation of CD31 (pCD31), caused cerebrovasculature damage marked by shortened capillary lengths (Figure 2), leading to the extravasation of T lymphocytes and the development of some AD pathological markers particularly in the ApoE4 brain (Figure 3).